Table of Contents
From the Editor
- Cytokines and the still-baffling clinical biology of COVID-19
The primary culprit is not certain. Is it all immune damage, or is the continued persistence of coronavirus playing a role?
COVID-19 Curbside Consult
- Clinical presentation and course of COVID-19
Information about the clinical presentation and course of COVID-19 is rapidly evolving.
- Cytokine storm and the prospects for immunotherapy with COVID-19
Despite gaping holes in our knowledge, treatment is evolving.
The Clinical Picture
- Firm lesion on the lateral thigh
A 41-year-old man presented with concern about a lesion he had first noticed 6 years earlier.
- Mönckeberg medial sclerosis
A man with chronic kidney disease presents with pain and ulceration of the fingers.
1-Minute Consult
- Does a short QT interval increase the risk of cardiac death in healthy people?
No, but it may warrant further investigation to determine if the patient is at risk.
Interpreting Key Trials
- The role of ISCHEMIA in stable ischemic heart disease
Decisions regarding treatment of stable ischemic heart disease must remain individualized.
Review
- Glucocorticoid-induced osteoporosis: Insights for the clinician
Glucocorticoids cause significant bone loss, predominantly affecting trabecular bone, with consequent fragility fractures.
- Optimize your documentation to improve Medicare reimbursement
There’s nothing more frustrating than not getting credit for work performed.
- Procedures and devices to treat resistant hypertension in chronic kidney disease
These treatments show potential. All but renal artery stenting are still experimental.
Editorial
- Device-based therapies for resistant hypertension in chronic kidney disease: The continuing quest for a cure
Device-based therapies have shown promise, but many points still need clarification.
Commentary
Stable coronary artery disease needs a patient-centered approach, and one size does not fit all.